• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

BII

Pluripotent parthenogenetic stem cells (pSCs) may be derived by pharmacological activation

February 11, 2018 by Katherine Lewis Leave a Comment

Pluripotent parthenogenetic stem cells (pSCs) may be derived by pharmacological activation of unfertilized oocytes. line with our observation, Rosa et al. showed that native myocardium does not express MHC class I antigens, but after transplantation these antigens can be induced (28). It was demonstrated that fetal and adult myocytes express very low levels of MHC … [Read more…]

Posted in: Blogging Tagged: BII, S/GSK1349572

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by